Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Income Statement
Earnings Waterfall
Shenzhen Salubris Pharmaceuticals Co Ltd
Revenue
|
3.4B
CNY
|
Cost of Revenue
|
-1.1B
CNY
|
Gross Profit
|
2.3B
CNY
|
Operating Expenses
|
-1.7B
CNY
|
Operating Income
|
630.2m
CNY
|
Other Expenses
|
-50.1m
CNY
|
Net Income
|
580.1m
CNY
|
Income Statement
Shenzhen Salubris Pharmaceuticals Co Ltd
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
2 328
N/A
|
2 451
+5%
|
2 570
+5%
|
2 686
+5%
|
2 883
+7%
|
3 015
+5%
|
3 237
+7%
|
3 467
+7%
|
3 478
+0%
|
3 610
+4%
|
3 712
+3%
|
3 739
+1%
|
3 834
+3%
|
3 891
+1%
|
3 976
+2%
|
4 106
+3%
|
4 154
+1%
|
4 308
+4%
|
4 386
+2%
|
4 587
+5%
|
4 652
+1%
|
4 714
+1%
|
4 741
+1%
|
4 681
-1%
|
4 471
-4%
|
4 148
-7%
|
3 650
-12%
|
3 040
-17%
|
2 739
-10%
|
2 638
-4%
|
2 579
-2%
|
2 792
+8%
|
3 058
+10%
|
3 228
+6%
|
3 350
+4%
|
3 419
+2%
|
3 482
+2%
|
3 434
-1%
|
3 498
+2%
|
3 390
-3%
|
3 365
-1%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(600)
|
(630)
|
(678)
|
(716)
|
(764)
|
(842)
|
(935)
|
(1 024)
|
(912)
|
(1 004)
|
(1 023)
|
(1 023)
|
(950)
|
(1 002)
|
(962)
|
(909)
|
(785)
|
(878)
|
(893)
|
(943)
|
(944)
|
(1 052)
|
(1 052)
|
(1 076)
|
(965)
|
(999)
|
(1 026)
|
(915)
|
(848)
|
(876)
|
(759)
|
(795)
|
(811)
|
(860)
|
(889)
|
(940)
|
(1 001)
|
(1 064)
|
(1 147)
|
(1 165)
|
(1 065)
|
|
Gross Profit |
1 727
N/A
|
1 820
+5%
|
1 892
+4%
|
1 970
+4%
|
2 119
+8%
|
2 173
+3%
|
2 302
+6%
|
2 444
+6%
|
2 565
+5%
|
2 606
+2%
|
2 689
+3%
|
2 716
+1%
|
2 884
+6%
|
2 888
+0%
|
3 015
+4%
|
3 198
+6%
|
3 369
+5%
|
3 430
+2%
|
3 494
+2%
|
3 644
+4%
|
3 708
+2%
|
3 662
-1%
|
3 689
+1%
|
3 605
-2%
|
3 506
-3%
|
3 149
-10%
|
2 624
-17%
|
2 126
-19%
|
1 891
-11%
|
1 763
-7%
|
1 820
+3%
|
1 997
+10%
|
2 247
+13%
|
2 368
+5%
|
2 461
+4%
|
2 479
+1%
|
2 481
+0%
|
2 370
-4%
|
2 351
-1%
|
2 225
-5%
|
2 300
+3%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(779)
|
(813)
|
(842)
|
(866)
|
(949)
|
(931)
|
(971)
|
(1 044)
|
(1 108)
|
(1 107)
|
(1 159)
|
(1 148)
|
(1 284)
|
(1 270)
|
(1 386)
|
(1 537)
|
(1 711)
|
(1 705)
|
(1 742)
|
(1 909)
|
(2 014)
|
(2 068)
|
(2 176)
|
(2 391)
|
(2 618)
|
(2 479)
|
(2 252)
|
(1 764)
|
(1 515)
|
(1 652)
|
(1 646)
|
(1 751)
|
(1 696)
|
(1 929)
|
(2 059)
|
(2 058)
|
(1 877)
|
(1 784)
|
(1 719)
|
(1 634)
|
(1 670)
|
|
Selling, General & Administrative |
(774)
|
(812)
|
(840)
|
(864)
|
(819)
|
(926)
|
(964)
|
(1 037)
|
(927)
|
(1 101)
|
(1 150)
|
(1 139)
|
(1 029)
|
(1 265)
|
(1 387)
|
(1 310)
|
(1 363)
|
(1 436)
|
(1 471)
|
(1 763)
|
(1 572)
|
(1 780)
|
(1 778)
|
(1 740)
|
(1 800)
|
(1 802)
|
(1 598)
|
(1 388)
|
(1 068)
|
(1 062)
|
(1 095)
|
(1 192)
|
(1 258)
|
(1 468)
|
(1 499)
|
(1 481)
|
(1 325)
|
(1 271)
|
(1 271)
|
(1 217)
|
(1 311)
|
|
Research & Development |
0
|
0
|
0
|
0
|
(121)
|
0
|
0
|
0
|
(176)
|
0
|
0
|
0
|
(224)
|
0
|
0
|
0
|
(327)
|
0
|
0
|
(215)
|
(382)
|
(340)
|
(454)
|
(703)
|
(690)
|
(721)
|
(706)
|
(436)
|
(335)
|
(369)
|
(324)
|
(318)
|
(327)
|
(378)
|
(475)
|
(502)
|
(500)
|
(516)
|
(453)
|
(432)
|
(376)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(30)
|
0
|
0
|
0
|
(52)
|
0
|
0
|
0
|
(113)
|
0
|
0
|
0
|
(190)
|
0
|
0
|
0
|
(181)
|
0
|
0
|
0
|
(165)
|
0
|
0
|
0
|
(83)
|
0
|
0
|
0
|
(70)
|
|
Other Operating Expenses |
(5)
|
(2)
|
(2)
|
(2)
|
(0)
|
(5)
|
(7)
|
(7)
|
6
|
(6)
|
(9)
|
(9)
|
(1)
|
(6)
|
1
|
(227)
|
30
|
(269)
|
(272)
|
70
|
52
|
52
|
57
|
52
|
61
|
45
|
52
|
60
|
70
|
(220)
|
(226)
|
(241)
|
54
|
(83)
|
(85)
|
(76)
|
32
|
3
|
4
|
14
|
88
|
|
Operating Income |
949
N/A
|
1 007
+6%
|
1 051
+4%
|
1 104
+5%
|
1 170
+6%
|
1 243
+6%
|
1 331
+7%
|
1 399
+5%
|
1 457
+4%
|
1 499
+3%
|
1 530
+2%
|
1 568
+2%
|
1 600
+2%
|
1 618
+1%
|
1 629
+1%
|
1 661
+2%
|
1 658
0%
|
1 726
+4%
|
1 751
+1%
|
1 736
-1%
|
1 695
-2%
|
1 594
-6%
|
1 513
-5%
|
1 213
-20%
|
888
-27%
|
670
-25%
|
372
-45%
|
363
-2%
|
376
+4%
|
112
-70%
|
174
+56%
|
246
+41%
|
551
+124%
|
439
-20%
|
402
-8%
|
421
+5%
|
605
+44%
|
586
-3%
|
631
+8%
|
591
-6%
|
630
+7%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
19
|
22
|
28
|
31
|
38
|
36
|
29
|
27
|
21
|
26
|
32
|
36
|
31
|
37
|
38
|
28
|
43
|
41
|
40
|
49
|
26
|
22
|
4
|
(4)
|
(30)
|
(32)
|
(26)
|
(34)
|
(14)
|
(24)
|
(39)
|
(38)
|
(23)
|
232
|
292
|
334
|
106
|
111
|
95
|
68
|
77
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
(2)
|
0
|
12
|
0
|
12
|
12
|
(1)
|
0
|
0
|
0
|
(14)
|
(1)
|
(0)
|
(1)
|
(284)
|
0
|
(0)
|
(1)
|
56
|
(1)
|
(2)
|
(0)
|
16
|
(1)
|
(0)
|
(0)
|
(53)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(0)
|
(1)
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
9
|
9
|
12
|
14
|
11
|
10
|
9
|
11
|
13
|
18
|
20
|
19
|
22
|
22
|
25
|
25
|
2
|
(7)
|
(20)
|
(23)
|
(13)
|
(17)
|
6
|
1
|
7
|
9
|
(14)
|
(21)
|
(21)
|
(24)
|
(22)
|
14
|
16
|
11
|
12
|
(14)
|
(13)
|
(9)
|
(8)
|
(8)
|
(12)
|
|
Pre-Tax Income |
976
N/A
|
1 037
+6%
|
1 090
+5%
|
1 148
+5%
|
1 217
+6%
|
1 289
+6%
|
1 369
+6%
|
1 437
+5%
|
1 492
+4%
|
1 543
+3%
|
1 581
+2%
|
1 621
+3%
|
1 651
+2%
|
1 677
+2%
|
1 692
+1%
|
1 715
+1%
|
1 715
+0%
|
1 759
+3%
|
1 784
+1%
|
1 774
-1%
|
1 706
-4%
|
1 599
-6%
|
1 524
-5%
|
1 211
-21%
|
851
-30%
|
646
-24%
|
331
-49%
|
307
-7%
|
57
-82%
|
64
+13%
|
112
+75%
|
220
+96%
|
600
+172%
|
681
+14%
|
705
+3%
|
740
+5%
|
714
-4%
|
688
-4%
|
718
+4%
|
650
-9%
|
642
-1%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(143)
|
(150)
|
(152)
|
(157)
|
(174)
|
(187)
|
(203)
|
(218)
|
(222)
|
(230)
|
(239)
|
(243)
|
(260)
|
(272)
|
(271)
|
(278)
|
(278)
|
(283)
|
(283)
|
(273)
|
(252)
|
(236)
|
(227)
|
(213)
|
(170)
|
(135)
|
(87)
|
(55)
|
(7)
|
(12)
|
(23)
|
(44)
|
(72)
|
(67)
|
(61)
|
(62)
|
(79)
|
(82)
|
(95)
|
(77)
|
(61)
|
|
Income from Continuing Operations |
833
|
887
|
938
|
991
|
1 043
|
1 102
|
1 165
|
1 219
|
1 270
|
1 313
|
1 342
|
1 378
|
1 390
|
1 405
|
1 421
|
1 438
|
1 437
|
1 476
|
1 502
|
1 501
|
1 455
|
1 363
|
1 297
|
998
|
682
|
511
|
244
|
253
|
50
|
53
|
89
|
176
|
528
|
613
|
644
|
679
|
634
|
606
|
623
|
573
|
581
|
|
Income to Minority Interest |
(3)
|
(4)
|
(6)
|
(2)
|
(1)
|
0
|
1
|
(2)
|
(4)
|
(3)
|
(1)
|
1
|
6
|
10
|
12
|
13
|
15
|
15
|
10
|
7
|
4
|
1
|
5
|
28
|
33
|
33
|
35
|
13
|
11
|
13
|
12
|
9
|
5
|
3
|
1
|
2
|
3
|
4
|
4
|
3
|
(1)
|
|
Net Income (Common) |
830
N/A
|
883
+6%
|
933
+6%
|
989
+6%
|
1 042
+5%
|
1 102
+6%
|
1 166
+6%
|
1 217
+4%
|
1 266
+4%
|
1 310
+3%
|
1 341
+2%
|
1 380
+3%
|
1 396
+1%
|
1 415
+1%
|
1 432
+1%
|
1 451
+1%
|
1 452
+0%
|
1 491
+3%
|
1 511
+1%
|
1 508
0%
|
1 458
-3%
|
1 365
-6%
|
1 301
-5%
|
1 025
-21%
|
715
-30%
|
544
-24%
|
279
-49%
|
266
-5%
|
61
-77%
|
66
+8%
|
101
+54%
|
185
+83%
|
534
+188%
|
616
+15%
|
645
+5%
|
681
+6%
|
637
-6%
|
611
-4%
|
626
+3%
|
577
-8%
|
580
+1%
|
|
EPS (Diluted) |
0.79
N/A
|
0.84
+6%
|
0.89
+6%
|
0.94
+6%
|
1
+6%
|
1.05
+5%
|
1.11
+6%
|
1.16
+5%
|
1.21
+4%
|
1.25
+3%
|
1.28
+2%
|
1.32
+3%
|
1.33
+1%
|
1.35
+2%
|
1.37
+1%
|
1.39
+1%
|
1.39
N/A
|
1.43
+3%
|
1.45
+1%
|
1.44
-1%
|
1.39
-3%
|
1.3
-6%
|
1.24
-5%
|
0.98
-21%
|
0.68
-31%
|
0.52
-24%
|
0.27
-48%
|
0.26
-4%
|
0.06
-77%
|
0.07
+17%
|
0.09
+29%
|
0.19
+111%
|
0.5
+163%
|
0.58
+16%
|
0.55
-5%
|
0.64
+16%
|
0.58
-9%
|
0.55
-5%
|
0.57
+4%
|
0.52
-9%
|
0.52
N/A
|